The dose of contrast material can be effectively reduced by at least 10% for elderly patients undergoing a multi-detector CT examination of the pancreas and biliary region a new study finds. When the ...

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...

Designed for contrast media injections, the PowrSyringe is capable of an injection that is between 20 and 100% faster than a standard control syringe. Nothing beats the need for speed when it comes to ...

Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. 53% of patients with an iodinated contrast allergy and ...

Breast cancer remains one of the most prevalent cancers worldwide, accounting for 11.7 per cent of all cancer cases. In India, it is a leading cause of cancer-related deaths among […] ...

In the U.S., Elucirem is indicated in adults and now in pediatric patients including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal ...